Frequency Therapeutics, based in Woburn, MA, is a pioneering biotech company focused on RNA editing to revolutionize the future of medicine. Their groundbreaking platform, Oligonucleotide Promoted Editing of RNA (OPERA), is inspired by natural processes and holds great promise in rewriting genetic instructions to develop innovative treatments for patients.
Korro Bio, the team behind Frequency Therapeutics, is driven by a passion to discover new pathways and transform scientific insights into life-changing therapies for individuals with debilitating and life-threatening diseases. By simplifying historically complex methodologies, they deliver sophisticated treatments that have the potential to make a significant impact on patient lives.
Generated from the website